Visualitza per autor "Delaloge, Suzette"
Ara mostrant els elements 1-3 d 3
-
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY
Fasching, Peter A.; Couch, Fergus; Delaloge, Suzette; labidi-galy, sana intidhar; O’Shaughnessy, Joyce; Balmaña, Judith (Springer, 2024-04) -
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial
Hurvitz, Sara; Antunes de Melo Oliveira, Ana Mafalda; Trudeau, Maureen E.; Moy, Beverly; Saura Manich, Cristina; Delaloge, Suzette (Wiley, 2021-08) -
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
de Azambuja, Evandro; Trapani, Dario; Loibl, Sibylle; Senkus, Elzbieta; Criscitiello, Carmen; Cortés Castan, Javier; Delaloge, Suzette (BMJ, 2020-05-20)